Inari Short Long Term Debt Total from 2010 to 2024

NARI Stock  USD 50.83  1.35  2.73%   
Inari Medical's Short and Long Term Debt Total is increasing with slightly volatile movements from year to year. Short and Long Term Debt Total is predicted to flatten to about 27 M. For the period between 2010 and 2024, Inari Medical, Short and Long Term Debt Total quarterly trend regression had mean deviation of  8,818,943 and range of 22.5 M. View All Fundamentals
 
Short and Long Term Debt Total  
First Reported
2010-12-31
Previous Quarter
32 M
Current Value
27 M
Quarterly Volatility
9.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Inari Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inari Medical's main balance sheet or income statement drivers, such as Net Interest Income of 16.2 M, Interest Income of 16.4 M or Depreciation And Amortization of 11.3 M, as well as many indicators such as Price To Sales Ratio of 7.09, Dividend Yield of 0.0 or PTB Ratio of 8.32. Inari financial statements analysis is a perfect complement when working with Inari Medical Valuation or Volatility modules.
  
Check out the analysis of Inari Medical Correlation against competitors.
For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.

Latest Inari Medical's Short Long Term Debt Total Growth Pattern

Below is the plot of the Short Long Term Debt Total of Inari Medical over the last few years. It is Inari Medical's Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inari Medical's overall financial position and show how it may be relating to other accounts over time.
Short Long Term Debt Total10 Years Trend
Slightly volatile
   Short Long Term Debt Total   
       Timeline  

Inari Short Long Term Debt Total Regression Statistics

Arithmetic Mean17,185,529
Geometric Mean14,911,262
Coefficient Of Variation56.63
Mean Deviation8,818,943
Median9,836,410
Standard Deviation9,732,641
Sample Variance94.7T
Range22.5M
R-Value0.85
Mean Square Error27.5T
R-Squared0.73
Significance0.00005
Slope1,859,776
Total Sum of Squares1326.1T

Inari Short Long Term Debt Total History

202427 M
202332 M
202232.3 M
202029.2 M
201919.5 M

About Inari Medical Financial Statements

Investors use fundamental indicators, such as Inari Medical's Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Although Inari Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Short and Long Term Debt Total32 M27 M

Currently Active Assets on Macroaxis

When determining whether Inari Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inari Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inari Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inari Medical Stock:
Check out the analysis of Inari Medical Correlation against competitors.
For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inari Medical. If investors know Inari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inari Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.84)
Earnings Share
(1.35)
Revenue Per Share
9.901
Quarterly Revenue Growth
0.214
Return On Assets
(0.03)
The market value of Inari Medical is measured differently than its book value, which is the value of Inari that is recorded on the company's balance sheet. Investors also form their own opinion of Inari Medical's value that differs from its market value or its book value, called intrinsic value, which is Inari Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inari Medical's market value can be influenced by many factors that don't directly affect Inari Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inari Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inari Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inari Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.